Latest News in the pharma Industry

All

CPhI expands in Middle East & Africa with Abu Dhabi event in 2018

CPhI expands in Middle East & Africa with Abu Dhabi event in 2018

1 Mar 2017

CPhI Middle East & Africa is a natural progression and rebrand of the rapid growth seen at CPhI Istanbul.

Read more 
Lilly completes acquisition of CoLucid Pharmaceuticals

Lilly completes acquisition of CoLucid Pharmaceuticals

1 Mar 2017

Acquisition enhances Lilly's existing pain management.

Read more 
FDA accepts BLA for avelumab for the treatment of metastatic urothelial carcinoma for Priority Review

FDA accepts BLA for avelumab for the treatment of metastatic urothelial carcinoma for Priority Review

28 Feb 2017

Second Biologics License Application accepted by the FDA for avelumab.

Read more 
Pharma's most innovative companies; the 2017 ranking

Pharma's most innovative companies; the 2017 ranking

28 Feb 2017

Innovation is being driven increasingly by smaller, possibly more agile, companies.

Read more 
Malvern launches MicroCal PEAQ-DSC for faster, more accurate characterization of protein and biomolecule stability

Malvern launches MicroCal PEAQ-DSC for faster, more accurate characterization of protein and biomolecule stability

28 Feb 2017

Supports a wide range of needs across the biopharma development cycle.

Read more 
Merck launches integrity test system for verification of filters and processing equipment

Merck launches integrity test system for verification of filters and processing equipment

27 Feb 2017

New model incorporates an improved algorithm to simplify test creation and accelerate test completion.

Read more 
Sanofi and Lonza join hands to establish large-scale biologics production facility

Sanofi and Lonza join hands to establish large-scale biologics production facility

27 Feb 2017

Partnership leverages Lonza's expertise in large-scale mammalian cell culture facilities alongside Sanofi's strength in developing and launching biologics based treatments.

Read more 
CHMP recommends EU Conditional Marketing Authorisation for Natpar for patients with chronic hypoparathyroidism

CHMP recommends EU Conditional Marketing Authorisation for Natpar for patients with chronic hypoparathyroidism

27 Feb 2017

If approved, Natpar would be the first licensed recombinant parathyroid hormone in Europe for the management of chronic hypoparathyroidism, the only endocrine-deficiency disorder with no hormone treatment.

Read more 
Novartis receives positive CHMP opinion for Tafinlar + Mekinist in BRAF-positive NSCLC patients

Novartis receives positive CHMP opinion for Tafinlar + Mekinist in BRAF-positive NSCLC patients

26 Feb 2017

If approved, Tafinlar + Mekinist will be the first targeted therapy specifically for NSCLC patients with a BRAF V600 mutation.

Read more 
Endo Pharmaceuticals recalls one lot of Edex

Endo Pharmaceuticals recalls one lot of Edex

26 Feb 2017

Recall due to potential lack of sterility assurance.

Read more 
Real-world data show lower risk of stroke and major bleeding for Pradaxa compared with warfarin

Real-world data show lower risk of stroke and major bleeding for Pradaxa compared with warfarin

26 Feb 2017

Compared with warfarin, Pradaxa was associated with a 26% reduced risk of stroke and a 20% reduced risk of major bleeding.

Read more 
SGS platform provides modeling and simulation solutions for clinical trials

SGS platform provides modeling and simulation solutions for clinical trials

23 Feb 2017

Tool explores the time course of drug exposure, biomarker response and outcome.

Read more